Lipin-1 Deficiency-Associated Recurrent Rhabdomyolysis and Exercise-Induced Myalgia Persisting into Adulthood: A Case Report and Review of Literature

Phosphatidate phosphatase-1 (lipin-1) is encoded by LPIN1 gene. Lipin-1 deficiency has been reported as the second most common cause of early-onset rhabdomyolysis after primary fatty acid oxidation disorders. We report a case of a 32-year-old Sri Lankan female with a history of more than 10 episodes of rhabdomyolysis and exercise intolerance since childhood. These episodes were triggered by infections and exercise. A temporal relationship between the acute episodes and use of drugs such as theophylline, mefenamic acid, co-trimoxazole, and combined oral contraceptive pills was also noted. There was marked elevation of serum creatine kinase and transaminases during acute episodes. Family history revealed parental consanguinity and an affected sibling who died of an acute episode associated with muscle weakness, dark coloured urine, and cyanosis, at the age of 2 years. The histochemical findings of the patient under discussion were consistent with a metabolic myopathy affecting membrane integrity. A homozygous, likely pathogenic variant c.1684G>T encoding p.(Glu562∗) was identified by clinical exome sequencing. Even though the studies to date give no convincing evidence of a possible causal or contributory relationship between the drugs under discussion and lipin-1 related rhabdomyolysis, this case highlights the importance of pharmacovigilance and reporting adverse drug reactions in patients with lipin-1 deficiency.

[1]  N. Forrester,et al.  A rare case of adult onset LPIN1 associated rhabdomyolysis , 2020, Neuromuscular Disorders.

[2]  W. Schmidt,et al.  Long‐term outcomes in a 25‐year‐old female affected with lipin‐1 deficiency , 2019, JIMD reports.

[3]  B. Long,et al.  An evidence‐based narrative review of the emergency department evaluation and management of rhabdomyolysis , 2019, The American journal of emergency medicine.

[4]  H. Ren,et al.  Lipin1 is required for skeletal muscle development by regulating MEF2c and MyoD expression , 2018, The Journal of physiology.

[5]  C. Morse,et al.  Oral contraceptive pill use and the susceptibility to markers of exercise-induced muscle damage , 2017, European Journal of Applied Physiology.

[6]  A. Gomes,et al.  Diclofenac induces proteasome and mitochondrial dysfunction in murine cardiomyocytes and hearts. , 2016, International journal of cardiology.

[7]  E. Rodrigues,et al.  LPIN1 deficiency: A novel mutation associated with different phenotypes in the same family , 2016, Molecular genetics and metabolism reports.

[8]  Huan-Ji Cheng,et al.  Potential factors involved in the causation of rhabdomyolysis following status asthmaticus , 2016, Allergy, Asthma & Clinical Immunology.

[9]  G. Carman,et al.  Redundant roles of the phosphatidate phosphatase family in triacylglycerol synthesis in human adipocytes , 2016, Diabetologia.

[10]  S. Jaradat,et al.  Molecular analysis of LPIN1 in Jordanian patients with rhabdomyolysis , 2015, Meta gene.

[11]  F. Sasarman,et al.  LPIN1 deficiency with severe recurrent rhabdomyolysis and persistent elevation of creatine kinase levels due to chromosome 2 maternal isodisomy , 2015, Molecular genetics and metabolism reports.

[12]  A. Augustyn,et al.  Rhabdomyolysis due to Trimethoprim-Sulfamethoxazole Administration following a Hematopoietic Stem Cell Transplant , 2015, Case reports in oncological medicine.

[13]  J. Zschocke,et al.  A novel therapeutic approach for LPIN1 mutation–associated rhabdomyolysis—The Austrian experience , 2015, Muscle & nerve.

[14]  B. Yakar,et al.  Diclofenac- and Pantoprazole-Induced Rhabdomyolysis: A Potential Drug Interaction , 2015, Drug Safety - Case Reports.

[15]  A. Mammen,et al.  Diagnostic evaluation of rhabdomyolysis , 2015, Muscle & nerve.

[16]  Fanny Mochel,et al.  An overview of inborn errors of complex lipid biosynthesis and remodelling , 2015, Journal of Inherited Metabolic Disease.

[17]  R. Wanders,et al.  Rhabdomyolysis: a review of the literature , 1993, Clinical Neurology and Neurosurgery.

[18]  F. Lamari,et al.  Disorders of phospholipids, sphingolipids and fatty acids biosynthesis: toward a new category of inherited metabolic diseases , 2013, Journal of Inherited Metabolic Disease.

[19]  A. Laquérriere,et al.  Fatal rhabdomyolysis in 2 children with LPIN1 mutations. , 2012, The Journal of pediatrics.

[20]  A. Munnich,et al.  Study of LPIN1, LPIN2 and LPIN3 in rhabdomyolysis and exercise-induced myalgia , 2012, Journal of Inherited Metabolic Disease.

[21]  Xiaowei Wang,et al.  Cardiac lipin 1 expression is regulated by the peroxisome proliferator activated receptor γ coactivator 1α/estrogen related receptor axis. , 2011, Journal of molecular and cellular cardiology.

[22]  Wolfgang Müller-Felber,et al.  LPIN1 gene mutations: a major cause of severe rhabdomyolysis in early childhood , 2010, Human mutation.

[23]  G. Carman,et al.  Characterization of the Human LPIN1-encoded Phosphatidate Phosphatase Isoforms* , 2010, The Journal of Biological Chemistry.

[24]  F. Khan Rhabdomyolysis: a review of the literature. , 2009, The Netherlands journal of medicine.

[25]  K. Reue The lipin family: mutations and metabolism , 2009, Current opinion in lipidology.

[26]  R. Houtkooper,et al.  Mutations in LPIN1 cause recurrent acute myoglobinuria in childhood. , 2008, American journal of human genetics.

[27]  Steven R Smith,et al.  Adipose tissue lipin-1 expression is correlated with peroxisome proliferator-activated receptor alpha gene expression and insulin sensitivity in healthy young men. , 2008, The Journal of clinical endocrinology and metabolism.

[28]  S. Klein,et al.  Hepatic Lipin 1β Expression Is Diminished in Insulin-Resistant Obese Subjects and Is Reactivated by Marked Weight Loss , 2007, Diabetes.

[29]  K. Reue,et al.  Three Mammalian Lipins Act as Phosphatidate Phosphatases with Distinct Tissue Expression Patterns* , 2006, Journal of Biological Chemistry.

[30]  K. Reue,et al.  Lipin Expression Is Attenuated in Adipose Tissue of Insulin-Resistant Human Subjects and Increases With Peroxisome Proliferator–Activated Receptor γ Activation , 2006, Diabetes.

[31]  J. Norwood,et al.  Trimethoprim-sulfamethoxazole associated rhabdomyolysis in a patient with AIDS: case report and review of the literature. , 2006, The American journal of the medical sciences.

[32]  P. Tiidus,et al.  Can oestrogen influence skeletal muscle damage, inflammation, and repair? , 2005, British Journal of Sports Medicine.

[33]  C. Bartal,et al.  Unmasking of carnitine palmitoyltransferase deficiency during an acute exacerbation of asthma complicated by rhabdomyolysis in a soldier. , 2004, Military medicine.

[34]  P. Clarkson,et al.  Oral contraceptive use and exercise-induced muscle damage and recovery. , 2002, Contraception.

[35]  J. Warren,et al.  Rhabdomyolysis: A review , 2002, Muscle & nerve.

[36]  P. Xu,et al.  Adipose tissue deficiency, glucose intolerance, and increased atherosclerosis result from mutation in the mouse fatty liver dystrophy (fld) gene. , 2000, Journal of lipid research.

[37]  S. Yamada,et al.  Possible mechanism of hepatocyte injury induced by diphenylamine and its structurally related nonsteroidal anti-inflammatory drugs. , 2000, The Journal of pharmacology and experimental therapeutics.

[38]  I. Ebihara,et al.  [A case of acute renal failure with rhabdomyolysis caused by the interaction of theophylline and clarithromycin]. , 1999, Nihon Jinzo Gakkai shi.

[39]  D. Grob,et al.  Diclofenac-lnduced Rhabdomyolysis , 1996 .

[40]  D. Grob,et al.  Diclofenac-induced rhabdomyolysis , 1996 .

[41]  M. Aoshima,et al.  [A case of theophylline-induced rhabdomyolysis following therapy of bronchial asthma]. , 1991, Nihon Kyobu Shikkan Gakkai zasshi.

[42]  J. Gordon,et al.  The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities. , 1989, The Journal of biological chemistry.